Automation, Digitization, and Robotics in Cell and Gene Therapy Manufacturing Market Size to Surge at a 18.70% CAGR, Reaching USD 5.28 Billion by 2035

According to Precedence Research, the global automation, digitization, and robotics in cell and gene therapy manufacturing market size will grow from USD 950 million in 2025 to nearly USD 5.28 billion by 2035, expanding at a CAGR of 18.70% from 2026 to 2035. This growth is driven by the increasing adoption of cutting-edge technologies to improve the precision of complex therapies. Automation and robotics are streamlining the production of these therapies, leading to more scalable, cost-effective, and compliant manufacturing processes.

Where Data Meets Strategic Clarity 📥 View Sample Pages of the Complete Report 👉 https://www.precedenceresearch.com/sample/8329

Market Size and Forecasts

🔹 Market size in 2025: USD 950.00 Million
🔹 Market size in 2026: USD 1,127.65 Million
🔹 Market size by 2035: USD 5.28 Billion
🔹 CAGR: 18.70% (2026-2035)
🔹 Forecast period: 2026-2035
🔹 Base year: 2025

AI's Role in Revolutionizing the Market

Artificial intelligence (AI) is playing an increasingly pivotal role in enhancing the precision and efficiency of manufacturing cell and gene therapies. AI-driven biosensors generate vast volumes of real-time data, enabling predictive insights that optimize every phase of the production process. By integrating AI into manufacturing execution systems (MES), companies can streamline workflows, enhance consistency, and reduce human error. This AI-powered innovation is unlocking the potential to scale complex therapies and ensure reproducibility across large production volumes.

Moreover, AI's integration with digital twins and predictive modeling systems is driving the evolution of smarter manufacturing processes. By enabling real-time simulation and process optimization, AI empowers manufacturers to bring cell and gene therapies to market faster while maintaining stringent quality standards.

🔗 What's Fueling the Next Wave of Growth? 👉 https://www.precedenceresearch.com/automation-digitization-and-robotics-in-cell-and-gene-therapy-manufacturing-market

Automation, Digitization, and Robotics in Cell and Gene Therapy Manufacturing Market Key Growth Drivers

🔸 Adoption of Advanced Manufacturing Solutions: More manufacturers are incorporating automation, digitization, and robotics into their production systems to increase operational efficiency and scalability.

🔸 Rising Regulatory Compliance: Automation tools help ensure adherence to strict regulatory standards, which is crucial in the production of therapies that must meet rigorous safety and quality control measures.

➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting

Automation, Digitization, and Robotics in Cell and Gene Therapy Manufacturing Market Opportunities

Commercialization of Advanced Therapies: As regulatory hurdles lower, the commercialization of therapies like gene editing and cell-based treatments is accelerating, creating a need for advanced manufacturing solutions that can scale production effectively.

Automation, Digitization, and Robotics in Cell and Gene Therapy Manufacturing Market Trends

🔸 Technological Advancements: Automation technologies like robotic cell handling and AI-driven manufacturing execution systems (MES) are revolutionizing the industry by enhancing production efficiency and precision.

🔸 In Vivo Therapy Manufacturing: The transition toward in vivo therapies, such as gene editing treatments, is increasing the need for scalable, high-precision robotic manufacturing systems.

🔸 Rising Demand for Advanced Therapies: With the surge in demand for CAR-T therapies and gene therapies, manufacturers are investing in automated systems that can handle the complexity and personalization of these therapies, ensuring consistent quality across production.

🔸 AI Integration: The integration of AI for real-time data collection and process optimization is transforming the manufacturing workflow, enabling higher precision and efficiency in the production of cell and gene therapies.

🔓 Instant Access. Zero Waiting. 📥 Buy the Premium Market Research Report Now 👉 https://www.precedenceresearch.com/checkout/8329

Automation, Digitization, and Robotics in Cell and Gene Therapy Manufacturing Market Regional Analysis

North America dominated with a 45% share in 2025, supported by advanced infrastructure, strong regulatory frameworks, and the presence of major biotechnology companies and CDMOs. The U.S. market is experiencing strong growth due to rapid adoption of advanced technologies and regulatory support. Expansion in viral vector production and cell processing capabilities is further boosting the market.

Europe held around 25% share in 2025 and is growing at a CAGR of 17%. Government funding, collaborations, and regulatory support are driving adoption of advanced therapy manufacturing technologies. Germany stands out as a key contributor due to strong investments and innovation.

Asia Pacific accounted for 22% share and is expected to grow at the fastest CAGR of 22.5%. Growth is driven by expanding biopharmaceutical capabilities, supportive government policies, and increasing healthcare demand. China plays a major role due to strong R&D efforts and infrastructure development.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy - Get the Sample Report@ https://www.precedenceresearch.com/sample/8329

Automation, Digitization, and Robotics in Cell and Gene Therapy Manufacturing Market Segment Analysis

🔹 Technology Analysis

The automated bioprocessing systems segment led the market with a 30% share in 2025. Its dominance is driven by the growing need for scalable, closed-system manufacturing that reduces contamination risks and ensures consistent results. These systems enable real-time monitoring and precise control of process parameters, helping minimize variability and improve reproducibility across batches.

Robotic cell handling and processing systems accounted for around 20% of the market in 2025 and are expected to grow at the fastest CAGR of 20.5%. Their adoption is increasing due to their ability to perform precise, sterile operations with minimal human intervention. This improves efficiency, consistency, and accuracy in complex cell processing workflows.

Digital Twin & Simulation Platforms segment held about 15% market share in 2025 and is projected to grow at a CAGR of 18%. Digital twins support process optimization, predictive modeling, and faster scale-up, reducing time-to-market. They also enable advanced simulations and data-driven decision-making across the manufacturing lifecycle.

AI-driven MES captured nearly 20% of the market in 2025 and is expected to grow at a CAGR of 19%. These systems enhance workflow management, data integration, and compliance tracking. Their analytics capabilities help improve efficiency and expand access to advanced therapies.

🔹 Automation Level Analysis

Semi-automated systems dominated with a 55% share in 2025 due to their cost-effectiveness and flexibility. They provide a balance between manual and automated processes, helping reduce labor costs while maintaining quality control.

Fully automated manufacturing platforms are expected to grow at the fastest CAGR of 22.5%. Their increasing adoption is driven by the need for large-scale production, improved consistency, and compliance with strict regulatory standards. These systems enhance speed, efficiency, and reduce production variability.

🔹 Application Analysis

Cell therapy manufacturing led the market with a 35% share in 2025. Growth is driven by the increasing use of CAR-T and stem cell therapies, which require highly controlled and automated production processes.

Gene Therapy Manufacturing segment accounted for around 30% market share and is expected to grow at a CAGR of 20%. Advancements in viral and non-viral delivery systems, such as lipid nanoparticles, are driving its expansion.

Process Development & Scale-Up holding about 15% share in 2025, this segment is growing at a CAGR of 17%. Automation tools help optimize processes and enable seamless transition from lab-scale to commercial production.

Quality Control & Release Testing with nearly 10% share, this segment is expected to grow at a CAGR of 16.5%. Increasing emphasis on product safety and regulatory compliance is driving the adoption of automated QC solutions.

🔹 End-Use Analysis

Biopharmaceutical companies held a 50% share in 2025 due to strong investments in advanced therapy manufacturing and robust infrastructure. Their ability to scale production and manage complex processes supports their leading position.

CDMOs accounted for 35% of the market and are projected to grow at the fastest CAGR of 20.5%. Rising outsourcing trends and demand for specialized manufacturing capabilities are fueling this growth.

Research Institutes & Academic Centers segment held around 15% share and is growing steadily at a CAGR of 16%. These institutions play a key role in early-stage research and development of innovative manufacturing technologies.

Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market Key Players

➢ Thermo Fisher Scientific Inc.
➢ Sartorius AG
➢ Danaher Corporation (Cytiva)
➢ Lonza Group AG
➢ Merck KGaA
➢ Fujifilm Diosynth Biotechnologies
➢ GE HealthCare Technologies Inc.
➢ Siemens AG
➢ ABB Ltd.
➢ Universal Robots A/S
➢ FANUC Corporation
➢ KUKA AG
➢ Rockwell Automation, Inc.
➢ Emerson Electric Co.
➢ Eppendorf SE

Latest Industry Updates

🔸 January 2026: The FDA introduced new regulatory flexibility for cell and gene therapy manufacturers, easing certain quality requirements to accelerate patient access.

🔸 July 2025: A UK consortium launched an automated cell therapy manufacturing platform, with an investment of $1.34 million aimed at scaling the production of cell therapies.

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

📥 Instant Report Delivery Available | 💳 Buy Now 👉 https://www.precedenceresearch.com/checkout/8329

Segments Covered in the Report

🔹 By Technology Type

Automated Bioprocessing Systems (Closed & Modular Systems)
Robotic Cell Handling & Processing Systems
Digital Twin & Simulation Platforms
AI-driven Manufacturing Execution Systems (MES)
Automated Quality Control & Analytics Systems

🔹 By Automation Level

Semi-automated Systems
Fully Automated Manufacturing Platforms

🔹 By Application

Cell Therapy Manufacturing (CAR-T, Stem Cell Therapy)
Gene Therapy Manufacturing (Viral Vectors, Non-viral Systems)
Process Development & Scale-up
Quality Control & Release Testing
Cold Chain & Logistics Automation

🔹 By End-Use

Biopharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMOs)
Research Institutes & Academic Centers
By Deployment Type

On-premise Automation Systems
Cloud-based Digital Manufacturing Platforms
Hybrid Digital-Physical Systems

🔹 By Region

North America
Latin America
Europe
Asia-pacific
Middle and East Africa

Connect With Us

📞 USA: +1 804 441 9344
📞 APAC: +61 485 981 310 or +91 87933 22019 | +6531051271
📞 Europe: +44 7383 092 044
📩 Email: sales@precedenceresearch.com

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

🌐 Web: https://www.precedenceresearch.com

Our Trusted Data Partners:
🔹https://www.towardshealthcare.com
🔹https://www.towardspackaging.com
🔹https://www.towardschemandmaterials.com
🔹https://www.towardsfnb.com
🔹https://www.marketstatsinsight.com

Get Recent News:
https://www.precedenceresearch.com/news

For the Latest Update, Follow Us:
🔹https://www.linkedin.com/company/precedence-research
🔹https://x.com/Precedence_R
🔹https://www.facebook.com/precedenceresearch
🔹https://precedence-research.medium.com/

This release was published on openPR.